Objectives: Recurrent respiratory papillomatosis (RRP) is a relatively rare, chronic disease caused by Human Papilloma Virus (HPV) 6 and 11, and characterized by wart-like lesions in the airway affecting voice and respiratory function. The majority of HPV infections are asymptomatic and resolve spontaneously, however, some individuals are afflicted with persistent HPV infections. Failure to eliminate HPV 6 and 11 due to a defect immune responsiveness to these specific genotypes is proposed to play a major role in the development of RRP. Methods: We performed a phenotypic characterization of peripheral blood mononuclear cells (PBMC) collected from 16 RRP patients and 12 age-matched healthy controls, using immunoflow cytometry, and monoclonal antibodies against differentiation and activation markers. The cytokine mRNA profile of monocytes, T helper-, T cytotoxic-, and NK cells was assessed using RT-qPCR cytokine analysis, differentiating between Th1-, Th2-, Th3/regulatory-, and inflammatory immune responses. Results: We found a dominance of cytotoxic T cells, activated NK cells, and high numbers of stressed MIC A/B expressing lymphocytes. There was an overall suppression of cytokine mRNA production and an aberrant cytokine mRNA profile in the activated NK cells. Conclusion: These findings demonstrate an immune dysregulation with inverted CD4 þ
Introduction
Though human papilloma virus (HPV) infection is extremely common in humans, recurrent respiratory papillomatosis (RRP) is a relatively uncommon disease worldwide, with an incidence range between 3.62-4.3/100,000 for juveniles and 1. .94/100,000 for adults [1, 2] . RRP is characterized by benign, wart-like lesions in the upper airway, and is associated with extensive morbidity due to its impact on voice and respiratory function, affecting quality of life [3] .
HPV is today the world's most common sexually transmitted disease [5] . However, a growing body of evidence supports the possibility that non-sexual transmission routes also could be of importance [6] . The majority of HPV infections are asymptomatic and clear spontaneously [7] . Why some HPV infections lead to chronic diseases requiring lifelong treatment is unclear. It is also unknown why some parts of the airway exhibit RRP lesions, while nearby airway mucosa does not, despite the presence of HPV [8] . The HPV specific cell-mediated immune system might be crucial in HPV-related tumor development, including RRP [9] .
There is compiling evidence that failure of HPV clearance and severity of RRP disease is associated with impaired/ dysregulated immune response. One report shows that RRP patients develop an ineffective HPV-specific, T-cell immune response [10] . Recently published work has further focused on the connection between HPV infections and the Th2-like immune response, in which CD4
þ T-cells induce expression of immunosuppressive cytokines (including IL-4 and IL-10) that suppress Th1 (cytotoxic) immunity [11, 12] . Patients with RRP express a parallel decrease in IFN-g, IL-12, and IL-18 [13] . In addition, an elevated Th2-like cytokine response has been associated with disease severity [10] . This imbalance of Th1/Th2-like cellular response could explain why RRP patients' immune systems fail to clear the HPV infection and are unable to prevent the reappearance of RRP. Dysfunctional natural killer (NK-) cells are present in RRP lesions, and they are unable to destroy HPV-infected keratinocytes [9] . The expression of major histocompatibility complex (MHC) antigens seems to play a role in patients with RRP through altered function of cell-mediated immunity [14] . MHC class I chain-related (MIC) A and B molecules, ligands of the activating NK-cell receptor NKG2D, have been reported as upregulated in number, and to exhibit differential expression among HPV-infected, and non-infected cell lines [15, 16] . The aim of this study was to characterize the phenotype of the peripheral blood mononuclear cells (PBMC) in RRP patients, in comparison to healthy controls. Our study outcome shows that a majority of the RRP patients had an inverted CD4 þ /CD8 þ ratio (<1 
Materials and Methods

Ethical permission
The study was conducted in accordance with the Declaration of Helsinki, and was approved by the Regional Ethical 
Study population
Blood samples were collected from 20 randomly selected RRP patients and 12 age-, gender-, and comorbiditymatched controls between January 2011 and May 2013. Randomization was secured as patients were included, when they needed treatment during the data gathering period. The control group was recruited from volunteers at the department of Otorhinolaryngology, University Hospital of Umeå, providing only venous blood samples. The RRP subjects were identified from patients who were diagnosed and/or treated at the tertiary referral center at the department of Otorhinolaryngology, University Hospital of Umeå. This department provides service (inquiry and surgical treatment) to a population of approximately 900,000 residents of the region ($4 inhabitants per square kilometer [2015] ). The sample size was determined by access of regional RRP patients during the study time and no power calculation was performed.
Exclusion criteria
After blood samples were collected, three RRP subjects were not analyzed further due to low numbers of viable PBMC and insufficient numbers to perform flow cytometry analyses. One patient was initially included but finally not analyzed due to low age, immature immune system, and absence of comparable age-matched control.
Inclusion criteria
The cut-off points for juvenile onset RRP versus adult onset RRP was defined as incidence at 18 years or younger in accordance to Omland et al. [17] . The indication for surgery was based on the subjective severity of symptoms and a detailed discussion with the patient or guardian. None of the eligible subjects smoked, and none of the juvenile RRP patients were premature at birth. Patients were included regardless of occurrence of allergy, gastroesophageal reflux disease (GERD), or asthma. The detailed outline of the patient characteristics is provided in Table 1 . The respiratory papilloma (glottic-, sub-, and supraglottic location) were addressed according to a locally modified Derkay staging assessment system. In contrast to Derkay et al. [18] , the goal was not to streamline the prediction of treatment intervals based on anatomical locations or symptom score, but rather to identify and describe the RRP lesions. Therefore, Derkay scores were not calculated. Data were stored in the northern Sweden RRP database. The main indications for surgery were hoarseness and mild airway obstruction (mild stridor at activity). Surgery was performed under general anesthesia using an AcuPulse Lumenis CO2 laser. All therapeutic interventions were performed by one otolaryngologist specialized and responsible for the RRP treatment in the northern region of Sweden (Katarina Olofsson, MD, PhD).
Patient samples, monoclonal antibodies, and consumables
Venous blood samples from 16 patients with RRP, and 12 healthy age-matched controls, were collected and analyzed. The clones and specificities of the monoclonal antibodies (mAbs) used in this study were as follows: anti-CD45-FITC/ CD14-PE (clone T29/33 and TUK4), anti-CD4-PE (clone MT310), anti-CD8-PE (clone DK25), anti-CD16-FITC (clone DJ130c), anti-CD19-PE (clone HD37) (DAKO Norden A/S, Glostrup, Denmark); anti-pan-gd-FITC (clone 5A6.E9) (Endogen, Thermo Fisher Scientific Inc., Rockford, IL); anti-CD56-PE (clone MY31), anti-NKG2D (clone 1D11), anti-pan MIC (clone 6D4) (BD Biosciences Pharmingen, Franklin Lakes, NJ); CD161-PE (clone HP-3G10) (BioLegend, London, United Kingdom). In the negative controls for indirect immunofluorescence staining, isotype-matched anti-mouse IgG subclass mAbs (clones DAK-GO1 and DAK-GO9) (DAKO Norden A/S, Glostrup, Denmark) were used, as well as secondary FITC-conjugated rabbit anti-goat IgG (Jackson ImmunoResearch Laboratories, Newmarket, Suffolk, United Kingdom). The following consumables for molecular work were used: RNeasy Mini kit (QIAGEN, Hilden, Germany); High-capacity cDNA Reverse 
Isolation of PBMC and purification of subpopulations of PBMC
Blood was drawn in EDTA-containing tubes and immediately processed for peripheral blood mononuclear cell (PBMC) isolation by a standard Lymphoprep 1 (Nycomed, Oslo, Norway) gradient centrifugation method as previously described [19, 20] . A part of the freshly isolated PBMC was used directly for immunofluorescent staining with monoclonal antibodies against phenotypic and activation markers and flow cytometry.
and CD56
þ cells were purified from the PBMC using positive selection with immunomagnetic beads (Dynabeads, Dynal Biotech, Thermo Fisher Scientific) coated with specific antibodies according to the manufacturer's instructions. The separated subpopulations were kept at À808C in RLT lysis buffer until molecular analyses were performed.
Im mu n of lo w c y t om et r y fo r ph e n o t y pi c characterization of PBMC One hundred thousand living cells per well, suspended in PBS containing 3% bovine calf serum and 0.05% sodium azide, were plated in U-shaped microtiter plates. For the analysis of most surface molecules, direct immunofluorescent staining with appropriate concentration of FITC-and/or 
Real-time quantitative reverse transcriptionpolymerase chain reaction (RT-qPCR)
A cytokine gene expression analysis was performed according to the MIQE requirements [21] . Cells bound to beads were dissolved in 350 ml of RLT lysis buffer (RNeasy Mini kit, QIAGEN, Hilden, Germany) and kept at À808C until total RNA extraction was performed. The RNA yield (on average 2574 ng in a total volume of 30 ml) and purity (average A260/A280 ratio 1.6) were assessed by NanoDrop N-1000 spectrophotometer (Thermo Fisher Scientific). Reverse transcription was done as previously described [19, 20, 22] to discriminate between T helper Th1-, Th2-, inflammatory-, and Th3 regulatory immune responses, was investigated using real time RT-qPCR and specific primers and probes. The relative cytokine expression between the two groups was calculated and compared, setting the cytokine expression in immune cells of patients with ''normal'' CD4 þ /CD8 þ ratio of >1 as a reference ¼ 1. The results are summarized in Figure 2A and B. In Figure 2A , the fold differences of the relative expression of 14 cytokines, expressed by four cell types are shown. Patients with CD4 þ /CD8 þ ratio >1 are referred to as the reference group ¼ 1. The cytokine mRNA expressions in patients with CD4 þ /CD8 þ ratio <1 are shown as histogram staples calculated in comparison to the reference group. There was a general downregulation of the cytotoxic response in patients with inverted CD4 þ /CD8 þ ratio. Noteworthy, the cytokines of crucial importance for clearing a viral infection, such as the Th1 cytokines IFNg, and IL-15, the pro-inflammatory cytokines IL-1b, IL-6, TNFa, and TNFb/lymphotoxin, were downregulated. The lymphotropic cytokine IL-2 was suppressed in all lymphocyte subpopulations but one (Fig. 2B) . In Figure 2B , the same relative cytokine mRNA expression is shown, grouped in individual figures for each tested lymphocyte subpopulation. Interestingly, there was an abnormal cytokine mRNA response in the CD56 þ NK-cells (Fig. 2B) . These NK-cells were the only cell types that upregulated IL-2 expression consistent with cell activation and clonal expansion.
However, their overall cytokine mRNA response is characterized by (i) inhibition of the typical NK-cell cytokines like IFNg, IL-15, TNFa, and b that promote Th1 response; (ii) aberrant expression and up-regulation of IL-4, IL-5, that is, switching the cytokine profile from cytotoxic/anti-viral/Th1 to humoral Th2 response; and (iii) up-regulation of IL-10, a regulatory cytokine that promotes adaptive peripheral Tr1 response, and immune suppression. Furthermore, the cytokine mRNA production by CD8 þ T cells that should be responding with a cytotoxic response is entirely suppressed. Similarly, there was a cytokine mRNA suppression in the CD4 þ T helper cells.
Discussion
The aim of the current study was to characterize the phenotype of peripheral blood lymphocytes in 16 RRP patients in comparison to 12 healthy age-and gendermatched controls using immunoflow cytometry. In addition, the cytokine mRNA profile was investigated for a panel of cytokines distinguishing between Th1-, Th2-, Th3/Tr1 regulatory, and inflammatory responses. Our results can be summarized as follows: (i) There was a statistically significant upregulation of the percentage of cytotoxic T cells in comparison to T helper cells in the peripheral blood of patients compared to controls resulting in an inverted CD4 þ /CD8 þ ratio (<1) in the majority of the RRP patients.
(ii) The NK-cell population in RRP patients was characterized by significantly elevated expression of the NK-cell receptors NKG2D and CD161 compared to normal controls. (iii) A large proportion of PBMC in RRP patients expressed the stress-related NKG2D ligands MIC A/B, making these cells potential targets for NK-cell attack. (iv) The cytokine mRNA profile in RRP patients with the lowest CD4 þ /CD8 þ ratio was generally suppressed in monocytes, T helper cells, cytotoxic T cells, and NK cells compared to patient with normal CD4 þ /CD8 þ ratio >1. In addition, the cytokine mRNAs expressed by the NK-cells had a dysregulated profile with downregulated IFNg mRNA expression, and upregulated immunosuppressive cytokines characteristic for regulatory response. An interesting observation was that the ratio of CD4 þ / CD8 þ in the peripheral blood of 12/16 RRP patients was inverted from the expected normal value >1-<1, a value commonly observed in HIV patients entering the AIDS phase of the disease [24] . In contrast, an earlier study from 1994 [14] did not detect any differences in T cell subsets, when comparing RRP patients to healthy individuals, however, they assumed that T suppressor cells could locally be involved in RRP. The diverging outcomes could be the result of differences in methods and study populations. At present, the reasons behind the inverted CD4 þ /CD8 þ ratio in RRP are not clear. However, one has to keep in mind blood of RRP patients, compared to healthy controls. MIC A/B molecules serve as molecules tagging DNA damaged cells and are expressed in various conditions of biological stress, such as malignant tumors [28] , viral and bacterial infections [29, 30] , and autoimmune conditions [31] . MIC A/B are ligands of the NKG2D receptor [32] responsible for elimination of stressed cells, serving as a major immune surveillance receptor [33, 34] . It has been shown that infections [29] , celiac disease [35] , and malignant tumors [28] 
/CD8
þ ratio, profoundly downregulated T helper cell response, and aberrant cytokine mRNA production by CD56 þ NK-cells.
Further studies are needed to elucidate the mechanism(s) behind these observations. The results from this report need to be interpreted with caution, due to small sample size, and moderate statistical power which might affect the reliability of the study outcome.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version of this article at the publisher's web-site. Table S2 . Fold-difference of cytokine mRNA expression level between the group of RRP patients with inverted CD4þ/ CD8þratio <1 and the reference group of RRP patients with normal CD4/CD8 ratio >1 (expression level ¼1).
